Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W C Wirshing

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Schizophrenia Bulletin|January 1, 1991
Neuroleptic plasma levelsT Van Putten, S R Marder, W C Wirshing, et al.
Biological Psychiatry|August 31, 2001
Risperidone-associated new-onset diabetesD A Wirshing, J M Pierre, J Eyeler, et al.
Psychopharmacology Bulletin|January 1, 1992
Acquisition and retention of skills training methods in chronic schizophrenic outpatientsW C Wirshing, S R Marder, T Eckman, et al.
Archives of General Psychiatry|August 1, 1990
Surreptitious noncompliance with oral fluphenazine in a voluntary inpatient populationT Van Putten, S R Marder, W C Wirshing, et al.
Journal of Clinical Psychopharmacology|October 1, 1990
Effects of clozapine on treatment-resistant akathisia and concomitant tardive dyskinesiaW C Wirshing, C K Phelan, T van Putten, et al.
The American Journal of Psychiatry|November 13, 1998
Informed consent: assessment of comprehensionD A Wirshing, W C Wirshing, S R Marder, et al.
Journal of Clinical Psychopharmacology|April 1, 1997
Hepatic encephalopathy associated with combined clozapine and divalproex sodium treatmentW C Wirshing, D Ames, S Bisheff, et al.
Biological Psychiatry|November 3, 1998
Novel antipsychotics and new onset diabetesD A Wirshing, B J Spellberg, S M Erhart, et al.
Archives of General Psychiatry|July 1, 1992
Fluoxetine, akathisia, and suicidality: is there a causal connection?W C Wirshing, T Van Putten, J Rosenberg, et al.
Schizophrenia Research|December 1, 2001
Fluphenazine plasma level monitoring for patients receiving fluphenazine decanoateS R Marder, M Aravagiri, W C Wirshing, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Schizophrenia Bulletin|January 1, 1991
Neuroleptic plasma levelsT Van Putten, S R Marder, W C Wirshing, et al.
Biological Psychiatry|August 31, 2001
Risperidone-associated new-onset diabetesD A Wirshing, J M Pierre, J Eyeler, et al.
Psychopharmacology Bulletin|January 1, 1992
Acquisition and retention of skills training methods in chronic schizophrenic outpatientsW C Wirshing, S R Marder, T Eckman, et al.
Archives of General Psychiatry|August 1, 1990
Surreptitious noncompliance with oral fluphenazine in a voluntary inpatient populationT Van Putten, S R Marder, W C Wirshing, et al.
Journal of Clinical Psychopharmacology|October 1, 1990
Effects of clozapine on treatment-resistant akathisia and concomitant tardive dyskinesiaW C Wirshing, C K Phelan, T van Putten, et al.
The American Journal of Psychiatry|November 13, 1998
Informed consent: assessment of comprehensionD A Wirshing, W C Wirshing, S R Marder, et al.
Journal of Clinical Psychopharmacology|April 1, 1997
Hepatic encephalopathy associated with combined clozapine and divalproex sodium treatmentW C Wirshing, D Ames, S Bisheff, et al.
Biological Psychiatry|November 3, 1998
Novel antipsychotics and new onset diabetesD A Wirshing, B J Spellberg, S M Erhart, et al.
Archives of General Psychiatry|July 1, 1992
Fluoxetine, akathisia, and suicidality: is there a causal connection?W C Wirshing, T Van Putten, J Rosenberg, et al.
Schizophrenia Research|December 1, 2001
Fluphenazine plasma level monitoring for patients receiving fluphenazine decanoateS R Marder, M Aravagiri, W C Wirshing, et al.
Pageof 5